← Browse by Condition
Medical Condition

esophageal adenocarcinoma

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 1
NCT06340711 Phase 2
Recruiting

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Enrollment
27 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT07284186 Phase 1
Recruiting

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
View Trial →
NCT00574327
Recruiting

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

Enrollment
3,000 pts
Location
United States
Sponsor
Midwest Biomedical Research Fo...
View Trial →
NCT06687603
Recruiting

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

Enrollment
800 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...
View Trial →
NCT06071845
Recruiting

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

Enrollment
400 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →